Adaptive Biotechnologies Announces FDA Acceptance of

The T-Cell Therapy product candidate contains a neoantigen-specific T-cell receptor (TCR) identified and characterized through Adaptive’s TCR discovery...

Related Keywords

Chad ,Karina Calzadilla ,Carrie Mendivil ,Erica Jones ,Drug Administration ,Adaptive Biotechnologies Corporation Nasdaq ,Gilmartin Group ,Exchange Commission ,Genentech ,Roche Group ,Biotechnologies Corporation ,Chad Robins ,T Cell Therapy ,Adaptive Biotechnologies ,Cell Therapy Collaboration ,Minimal Residual Disease ,Financial Condition ,Vice President ,Nasdaq Adpt ,Ncology ,Cell Therapy ,